Hoffmann, Marc Steven

Phase 1b Trial of Cereblon-Modulating Agents Iberdomide and CC-99282 Plus R-CHOP in Previously Untreated Aggressive B-Cell Lymphoma

Yeh, Su‐Peng , Gkasiamis, Argyrios, Patah, Poliana, Patel, Arpankumar , Nowakowski, Grzegorz S. , Westin, Jason R. , Martı́n, Alejandro , Hoffmann, Marc Steven , Vassilakopoulos, Theodoros P. , Li, Ju

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9475-9477

10.1182/blood-2022-162774